Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
6.08
-0.27 (-4.25%)
At close: Nov 16, 2026, 4:00 PM EST
6.19
+0.11 (1.81%)
After-hours: Nov 16, 2026, 7:33 PM EST
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $185.46 million as of November 16, 2026. It is the 20,811th most valuable company in the world and the 3,561st biggest in the United States. Its market cap has decreased by 4.40% in one year.
Market Cap
185.46M
Enterprise Value
122.82M
1-Year Change
-4.40%
Global Rank
Country Rank
#3,561 United States
Category
ChartMarket Cap Chart
Since November 14, 2023, Cartesian Therapeutics's market cap has increased from $166.07M to $185.46M, an increase of 11.68%. That is a compound annual growth rate of 3.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 185.46M | -1.08% |
| Dec 31, 2025 | 187.49M | -59.31% |
| Dec 31, 2024 | 460.74M | 330.61% |
| Dec 29, 2023 | 107.00M | -35.57% |
| Nov 14, 2023 | 166.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NervGen Pharma | 202.14M |
| Keros Therapeutics | 202.13M |
| Palisade Bio | 200.79M |
| ProQR Therapeutics | 198.98M |
| Compugen | 198.92M |
| Artiva Biotherapeutics | 198.22M |
| Pyxis Oncology | 188.98M |
| Korro Bio | 186.81M |